Methylation profiling with a panel of cancer related genes: Association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer

被引:100
|
作者
Ronneberg, Jo Anders [2 ,3 ]
Fleischer, Thomas [2 ,3 ]
Solvang, Hiroko Kato [2 ]
Nordgard, Silje H. [2 ]
Edvardsen, Hege [2 ]
Potapenko, Ivan [2 ]
Nebdal, Daniel [2 ]
Daviaud, Christian [4 ]
Gut, Ivo [4 ]
Bukholm, Ida [5 ]
Naume, Bjorn [7 ]
Borresen-Dale, Anne-Lise [2 ,3 ]
Tost, Joerg [4 ]
Kristensen, Vessela [1 ,2 ,3 ,6 ]
机构
[1] Dept Clin Mol Biol Epi Gen, Lorenskog, Norway
[2] Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway
[3] Univ Oslo, Fac Med, Inst Clin Med, N-0316 Oslo, Norway
[4] CEA, Inst Genom, Ctr Natl Genotypage, Lab Epigenet, F-91000 Evry, France
[5] Akershus Univ Hosp, Dept Surg, Nordbyhagen, Norway
[6] Univ Oslo, Fac Med, Inst Clin Epidemiol & Mol Biol EpiGen, N-0316 Oslo, Norway
[7] Oslo Univ Hosp Radiumhosp, Canc Clin, N-0310 Oslo, Norway
关键词
Breast cancer; DNA methylation; Homeobox genes; TP53; Epigenetics; Molecular classification; Gene expression; GENOME-WIDE ASSOCIATION; NF-KAPPA-B; BONE-MARROW; DNA HYPERMETHYLATION; MOLECULAR SUBTYPES; PROGNOSTIC-FACTORS; EPITHELIAL-CELLS; OSTEOPONTIN; EPIGENETICS; PROGRESSION;
D O I
10.1016/j.molonc.2010.11.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is a heterogeneous disease that can be divided in subtypes based on histology, gene expression profiles as well as differences in genomic aberrations. Distinct global DNA methylation profiles have been reported in normal breast epithelial cells as well as in breast tumors. However, the influence of the tumor methylome on the previously described subgroups of breast cancer is not fully understood. Here we report the DNA methylation profiles of 80 breast tumors using a panel of 807 cancer related genes interrogating 1505 CpG sites. We identified three major clusters based on the methylation profiles; one consisting of mainly tumors of myoepithelial origin and two other clusters with tumors of predominantly luminal epithelial origin. The clusters were different with respect to estrogen receptor status, TP53 status, ErbB2 status and grade. The most significantly differentially methylated genes including HDAC1, TFF1, OGG1, BMP3, FZD9 and HOXA11 were confirmed by pyrosequencing. Gene Ontology analysis revealed enrichment for genes involved in developmental processes including homeobox domain genes (HOXA9, HOXA11, PAX6, MYBL2, ISL1 and IPF1) and (ETS1, HDAC1, CREBBP, GAS7, SPI1 and TBX1). Extensive correlation to mRNA expression was observed. Pathway analyses identified a significant association with canonical (curated) pathways such as hepatic fibrosis including genes like EGF, NGFR and TNF, dendritic cell maturation and the NF-KB signaling pathway. Our results show that breast tumor expression subtypes harbor major epigenetic differences and tumors with similar gene expression profiles might belong to epigenetically different subtypes. Some of the transcription factors identified, with key roles in differentiation and development might play a role in inducing and maintaining the different phenotypes. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:61 / 76
页数:16
相关论文
共 50 条
  • [1] TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study
    Hurson, Amber N.
    Abubakar, Mustapha
    Hamilton, Alina M.
    Conway, Kathleen
    Hoadley, Katherine A.
    Love, Michael, I
    Olshan, Andrew F.
    Perou, Charles M.
    Garcia-Closas, Montserrat
    Troester, Melissa A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01) : 124 - 131
  • [2] Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer
    Meric-Bernstam, Funda
    Zheng, Xiaofeng
    Shariati, Maryam
    Damodaran, Senthil
    Wathoo, Chetna
    Brusco, Lauren
    Demirhan, Mehmet Esat
    Tapia, Coya
    Eterovic, Agda Karina
    Basho, Reva K.
    Ueno, Naoto T.
    Janku, Filip
    Sahin, Aysegul
    Rodon, Jordi
    Broaddus, Russell
    Kim, Tae-Beom
    Mendelsohn, John
    Shaw, Kenna R. Mills
    Tripathy, Debu
    Mills, Gordon B.
    Chen, Ken
    JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 15
  • [3] Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer
    A Langerød
    H Zhao
    Ø Borgan
    JM Nesland
    T Hernandez-Boussard
    IK Bukholm
    R Kåresen
    AL Børresen-Dale
    SS Jeffrey
    Breast Cancer Research, 7
  • [4] Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer
    Langerod, A
    Zhao, H
    Borgan, O
    Nesland, JM
    Hernandez-Boussard, T
    Bukholm, IK
    Kåresen, R
    Borresen-Dale, AL
    Jeffrey, SS
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S52 - S52
  • [5] TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
    Langerod, Anita
    Zhao, Hongjuan
    Borgan, Ornulf
    Nesland, Jahn M.
    Bukholm, Ida Rk
    Ikdahl, Tone
    Karesen, Rolf
    Borresen-Dale, Anne-Lise
    Jeffrey, Stefanie S.
    BREAST CANCER RESEARCH, 2007, 9 (03)
  • [6] TP53 pathway function, estrogen receptor status, and breast cancer risk factors in the Carolina Breast Cancer Study.
    Hurson, Amber N.
    Abubakar, Mustapha
    Conway-Dorsey, Kathleen
    Hoadley, Katherine
    Love, Michael I.
    Olshan, Andrew F.
    Garcia-Closas, Montserrat
    Troester, Melissa A.
    CANCER RESEARCH, 2021, 81 (13)
  • [7] Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas
    Angèle, S
    Treilleux, I
    Tanière, P
    Martel-Planche, G
    Vuillaume, M
    Bailly, C
    Brémond, A
    Montesano, R
    Hall, J
    CLINICAL CANCER RESEARCH, 2000, 6 (09) : 3536 - 3544
  • [8] TP53 Promoter Methylation in Primary Glioblastoma: Relationship with TP53 mRNA and Protein Expression and Mutation Status
    Jesionek-Kupnicka, Dorota
    Szybka, Malgorzata
    Malachowska, Beata
    Fendler, Wojciech
    Potemski, Piotr
    Piaskowski, Sylwester
    Jaskolski, Dariusz
    Papierz, Wielislaw
    Skowronski, Wieslaw
    Och, Waldemar
    Kordek, Radzislaw
    Zawlik, Izabela
    DNA AND CELL BIOLOGY, 2014, 33 (04) : 217 - 226
  • [9] TP53 Mutation Patterns in Breast Cancer Subgroups
    Dumay, A.
    Feugeas, J-P
    Wittmer, E.
    Lehmann-Che, J.
    Bertheau, P.
    Espie, M.
    de Cremoux, P.
    Andre, F.
    Sotiriou, C.
    Pusztai, L.
    de The, H.
    CANCER RESEARCH, 2011, 71
  • [10] TP53 mutation in triple negative breast cancer
    Nikolaidou, A.
    Botsfari, E.
    Goupou, E.
    Rouptsiou, E.
    Iosifidou, R.
    Patakiouta, F.
    VIRCHOWS ARCHIV, 2017, 471 : S302 - S302